Loading clinical trials...
Loading clinical trials...
A Single-Center, Randomized, Double-Masked, Parallel Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Reducing Ocular Itching in Subjects With Allergic Conjunctivitis
Conditions
Interventions
olopatadine hydrochloride ophthalmic solution 0.7%
loratadine 10 mg
+2 more
Locations
1
United States
Andover Eye Associates
Andover, Massachusetts, United States
Start Date
December 14, 2021
Primary Completion Date
April 23, 2022
Completion Date
April 23, 2022
Last Updated
May 3, 2022
NCT06686472
NCT05839938
NCT05186025
NCT01471184
NCT06602726
NCT05191186
Lead Sponsor
Andover Research Eye Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions